Directory · GB
Pharmaceutical Manufacturing in United Kingdom
A register of firms and the professionals working at them in the Pharmaceutical Manufacturing sector based in United Kingdom. Browse the public index, then filter or export on Kipplo.
Companies
3.2K on file
Pharmaron
Pharmaron: Global Life Sciences Services Provider Stock Code: 300759.SZ/3759.HK Founded in 2004, Pharmaron is a premier life sciences service provider that offers a broad spectrum of research, development, and manufacturing service capabilities throughout the entire drug discovery, preclinical, and clinical development process across multiple therapeutic modalities, including small molecules, biologics, and CGT products. Pharmaron’s Comprehensive CRO & CDMO Services • Synthetic, Medicinal, and Analytical Chemistry Services • Biology Services (e.g, in vitro screening, structural biology, biomarkers) • DMPK Services (e.g, in vitro ADME, in vivo PK, PKPD, mass balance) • Pharmacology Services (e.g, in vivo pharmacology, animal disease models, immunotoxicity) • Drug Safety Assessment Services (e.g, toxicology, safety pharmacology, genetic toxicology) • Radiochemistry and Isotopically Labelled Metabolism Services (e.g, 14C/Carbon-14 radiosynthesis, 3H/tritium radiosynthesis, QWBA, mARG) • CMC Services (e.g, API manufacturing, process chemistry, formulation development) • Clinical Development Services (e.g, First-in-Human [FIH], ethnobridging, microdosing Phase 0, absolute bioavailability) Commitment to Excellence and Innovation With a proven track record of success, Pharmaron continually invests in its people, facilities, and technologies to meet evolving scientific and regulatory demands. The company prides itself on enabling scientific breakthroughs and supporting its partners in advancing human Learn More: Explore Pharmaron’s services to discover how to accelerate your R&D programs. Keywords: CRO, CDMO, synthetic chemistry, medicinal chemistry, biology, radiochemistry, toxicology, First-in-Human, API manufacturing, PKPD, 14C radiosynthesis, discovery biologics, clinical development, small molecules, biologics, cell and gene therapy (CGT) products
10001+ staff
Lloydspharmacy
At LloydsPharmacy, part of Hallo Healthcare Group, a leading healthcare company, we strive to break boundaries, challenge the status quo and support the changing healthcare industry. We are committed to offering the best advice and service to our patients, customers and employees. It’s not just about dispensing medicines. Our holistic approach includes offering private consultations and medicine use reviews, and delivering free screening services as part of the national diabetes prevention programme, among many other things. This makes us the first port of call for customers who can’t get in to see their GP. We’re also revolutionising pharmacy in the UK in a number of different ways. For example, our innovative new healthcare centres allow patients to receive nurse-led infusions and injection treatments closer to home. We have also introduced prescription automated assembly solutions (PAS), which free up pharmacists to spend more one-to-one time with patients by taking repeat dispensing out of community pharmacies. Your career with us: There are so many different directions you could go in at LloydsPharmacy. We also provide outpatient dispensing services in hospitals and other pharmacy services to care homes, mental health facilities and prisons. To support you on your journey, we carry out regular performance reviews and have a range of learning options available, including both management and clinical training programmes. We may also be able to offer you relocation assistance, depending on where you’re going to be based. To find out more about our opportunities follow us @LloydsPharmacyCareers on Instagram and Facebook.
10001+ staff
Hallo Healthcare Group
Hallo Healthcare Group is the holding company brand name for some of the UK's leading healthcare organisations. Together, we are made up of LP HCS (Healthcare Services Ltd), AAH Pharmaceuticals ltd, LloydsPharmacy Clinical Homecare and Lloyds Online Doctor.
10001+ staff
Aflex Hose
We’re Watson-Marlow Fluid Technology Solutions - part of Spirax Group, a FTSE 100 Company. The World's Leading Manufacturer of PTFE Flexible Hose. Established 40 years ago, and in the years since then have invented and introduced all of the major innovations in PTFE hose product design and manufacturing technologies. From process fluid transfer lines in pharmaceutical plants to turbo-generator oil transfer lines in automobiles, Aflex Hose have developed flexible hose solutions which satisfy customers’ specialist requirements in these and many more industrial applications.
201 to 500 staff
Alimera
Alimera is a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer. For more information, please visit
51 to 200 staff
Endpoint Clinical
Clinical trials are designed around endpoints, but it’s the beginning that sets them up for success—including selecting the best RTSM partner for continuous and flexible support throughout the duration of a trial. With decades of experience, Endpoint Clinical is obsessed with proactive problem-solving, ensuring that issues are anticipated and resolved before they escalate, and any changes are easily incorporated. From day one, we become an extension of your team, seamlessly integrating into your trial operations. We minimize friction, reduce risk, and enable your clinical teams to focus where it matters most—on trial success. Endpoint is headquartered in Raleigh, NC, with offices across the US, EU, and Asia.
501 to 1000 staff
Hammersmith Medicines Research Ltd
HMR is a Contract Research Organisation (CRO). We specialise in and can provide a full service for phase 1 and early phase 2 studies. Our premises are spacious (5995 m²) and have 145 beds, a sleep unit for polysomnography, facilities for volunteers, laboratories, a pharmacy, including an aseptic unit and radiopharmacy, and offices. We have over 250 staff – 10 physicians, 35 nurses or nurse graduates, and over 200 graduates or PhD. We have done over 850 studies since 1993. HMR is one of the largest early-phase CROs in Europe.
201 to 500 staff
Ilc Dover
ILC Dover, an Ingersoll Rand Business, is a world leader in innovative design and production for biopharmaceutical, pharmaceutical, medical device, and aerospace markets. For over 25 years, we’ve led the industry in single-use powder and liquid handling, solving life sciences’ most complex workflow challenges. We deliver engineered solutions to improve your process so you can efficiently produce life-saving therapies. Trust ILC Dover to deliver innovative solutions that streamline your workflow from discovery through scale-up production, supporting your commitment to positive patient outcomes.
1001 to 5000 staff
Ucb
At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.
5001 to 10000 staff
Allergy Therapeutics
Allergy Therapeutics is a visionary immunology business with specialist experience in the research and development of allergy treatments. We have a well-established commercial presence in Europe and are focused on the US market. We specialise in the diagnosis and treatment of allergy. We mainly sell our products in European countries and our pipeline of products in clinical development includes vaccines for grass, tree and house dust mite, as well as a peanut allergy vaccine in pre-clinical development. Adjuvant systems to boost performance of vaccines outside of allergy are also under evaluation.
501 to 1000 staff
Catsci Ltd
CatSci Ltd is an award-winning innovation partner, dedicated to breaking down the silos in small molecules, TACS, glues and oligonucleotides CMC development to accelerate the delivery of life-changing medicines to patients. We proudly serve customers across the globe with projects, meeting their needs from candidate selection to product launch and beyond. Our tailored services include route scouting and selection, initial scale-up and risk management for early development. For later development, we provide process design, assessment and optimisation, scale-up for clinical and commercial manufacture, tech transfer and post-approval improvements. We possess a range of critical enabling technologies in research, development and manufacturing of small molecule and new modality therapeutics, with specialist facilities in chemical development, catalysis, material science, pre-formulation, HPAPI development, GMP analytical services, and oligonucleotide R&D and supply. Through our partnership with AGC Pharma Chemicals, we offer scalable small molecule API manufacturing, from grams to tonnes, with complete accountability of tech transfer. Agile, commercially minded and scientifically led, CatSci leverages its highly qualified technical team and state-of-the-art facilities to empower our customers to create affordable, best-in-class therapeutics in a safer, greener and more cost-effective way. Together, we can meet the evolving healthcare needs of the world. Recent recognition includes the 2024 Finance Awards Wales (ESG Excellence), the 2023 UK Fast Growth 50 Index Award (Innovative Growth), the Queen’s Award for Enterprise: International Trade 2022, the 2022 Bionow Awards (Export of the Year), the 2022 Inspire Business Awards (Business of the Year (25+ employees)), the 2022 Wales Business Awards (Workplace Wellbeing), the 2022 Wales STEM Awards (STEM Company of the Year (50+ Employees), and the 2022 Cardiff Business Award (International Business of the Year).
51 to 200 staff
Dermal Laboratories Ltd
Founded by a doctor in 1963, Dermal Laboratories, part of the family-owned Diomed Group, is one of the few truly independent UK pharmaceutical companies. For over 60 years we have focused on researching and developing innovative topical treatments primarily for prescription. A thorough understanding of the structure and biochemistry of the skin, the performance of the whole formulation, combined with recognising the concerns of healthcare professionals and the needs of patients, has been paramount in the design of Dermal’s topical treatments. This has led to significant advances in treatment through enhanced product efficacy and patient adherence. Dermal’s products are well known amongst Dermatologists, General Practitioners, Nurses and Pharmacists, and are widely prescribed for the treatment of a variety of skin disorders, as well as other conditions which can be treated by applied medication. A strong focus on excellence and reliability ensures we meet the highest standards of quality and performance while also prioritising sustainability and environmental responsibility.
51 to 200 staff
Huntingdon Life Sciences
Huntingdon Life Sciences was founded in 1952. In September 2015, the world leading contract research organisation was rebranded to form Envigo. This new organization has been created by the integration of Huntingdon Life Sciences, Harlan Laboratories, and three subsidiaries: GFA, NDA Analytics and LSR associates and provides essential products and research services for biopharmaceutical, crop protection, and chemical companies as well as universities, governments, and other research organizations. For company news, career opportunities and information about available products and services, follow Envigo's LinkedIn page.
1001 to 5000 staff
Mundipharma
Mundipharma is a global healthcare company with a presence across Africa, Asia Pacific, Canada, Europe, Latin America, and the Middle East. Mundipharma is dedicated to bringing innovative treatments to patients in the areas of Pain Management and Infectious Disease, as well as other severe and debilitating disease areas. Our guiding principles, centred around Integrity and Patient-Centricity, are at the heart of everything we do. We encourage our people to think differently and our inclusive culture of continuous learning and collaboration make Mundipharma a great place to work. For more information visit See our community guidelines: mundipharma.com/social-media-community-guidelines
1001 to 5000 staff
Panthera Biopartners
Panthera is an independent SMO working with pharmaceutical and contract research organizations to find the right patient, for the right trial, at the right time through the recruitment and retention of patients at its own dedicated research sites. Comprised of industry experts the Panthera team has come together to provide a professional, flexible and independent solution for clinical trials. Dr Ian Smith, the founder of Synexus (the world’s largest SMO) is one of the founders of Panthera along with Professor John Lyon, previously a global executive in CRO Covance. Jane Restorick has joined Panthera as Chief Operating Officer. Jane has extensive global experience in clinical trials and held the positions of COO and Chief Patient Officer at Synexus. Panthera is aimed at recruiting patients for and running clinical trials in therapy areas which are traditionally managed in primary care including: • Cardiac disease, • Allergies, • Migraine, • Osteoarthritis, • Osteoporosis, • Diabetes etc. Panthera intends to utilise innovative digital technologies to make clinical trials more accessible than ever for patients, customers and research staff and ensure that emerging technologies enabling the digitisation and virtualisation of trials is core to its strategy. Panthera clinical trial sites have been designed to welcome patients and ensure they have a professional and superior experience. All sites offer accessibility, comfortable surroundings and dedicated time with doctors and nurses to ensure the patients fully engage in the studies and are fully compliant. Sites are fitted with dedicated sample processing laboratories ensuring all trial processes are managed by fully qualified technical staff. All the professional staff at all Panthera sites are GCP trained, and have considerable experience in the running of clinical trials and providing timely, accurate data.
11 to 50 staff
Pharmacy Plus Limited
Pharmacy Plus is a leading pharmacy group specialising in medicines management solutions for care homes in the UK. The company has a long heritage of innovation and influence within the Care Home sector, being the first UK Pharmacy organisation to focus solely on the specific needs of residents and professional colleagues working within this industry. They deliver high quality patient services through innovation and the use of technology. Their products and services to Care Homes are cutting edge and unrivalled in the UK, and in some cases are the first in the world. The Company's mission is to enhance patient safety, personalise care and improve quality of life.
201 to 500 staff
Porton Biopharma Ltd
Porton Biopharma Limited (PBL) is a UK based company experienced in developing and manufacturing biopharmaceutical therapeutics and vaccines. PBL was corporatised out of Public Health England on 1st April 2015 to enable us to be better placed to grow our business, which is built upon decades of biopharmaceutical experience including the successful commercialisation and licensure of many therapies which now save thousands of lives every year, and generate revenues from world-wide sales. Our strategy as an evolving company with a distinguished heritage is to grow and develop our existing business and products, whilst also building relationships across the industry. As a growing company we are always looking to recruit talented individuals at all levels who have the drive and enthusiasm to help us get to where we want to be, and who are proud to be part of a team producing life-saving products that really make a difference. Visit our website to find out more and see a complete list of our latest vacancies.
51 to 200 staff
Soterius, Inc
We are Soterius – a strong team of experienced professionals from the pharma industry. We design customized, innovative, and cost-efficient processes for clinical safety, pharmacovigilance, and medical affairs. Our deep industry knowledge and up to date insights let us combine agile, people powered intelligence with big data in pioneering customer centric solutions. Find us at
51 to 200 staff
Adelphi Group
The Adelphi Group provides a wide range of strategic support services and consulting for global pharmaceutical clients. Adelphi is dedicated to the healthcare sector, providing services across strategic marketing, marketing and business intelligence, real-world observational research and disease-specific programmes, health and economic outcomes, market access, pricing and reimbursement, value insight, multi-channel health communications, scientific services, medical education, and strategic product development consultancy. Headquarters are located in Manchester, UK and New York with network offices throughout Europe and the US. The Adelphi Group employs over 700 people worldwide.
501 to 1000 staff
Essential Pharma
Essential Pharma is an international specialty pharmaceutical company dedicated to maintaining access to clinically differentiated, niche medicines in small patient populations. Our high-impact portfolio has a focus on the central nervous system (CNS), gastroenterology, ophthalmology, and rare disease, and our products treat patients in more than 70 countries. We are proactive in identifying low volume, difficult-to-manufacture therapeutic products, and late-stage clinical development assets that target rare diseases. We specialise in the acquisition of mature, established, branded medicines that are at risk of shortages or discontinuation, working with partners across the globe to ensure their continued manufacture to the highest standards. Essential Pharma comprises innovative and driven people who are passionate about ensuring continued supply of medicines to patients. We are committed to living by our values – Collaborative, Responsible, Trustworthy and Dynamic – and pride ourselves on our inclusive culture, where everyone's voice is valued and respected. We have an unwavering dedication to employee growth and believe in fostering an environment where all individuals can thrive. Watch our video to see why employees love working at Essential Pharma, and explore our current vacancies on the Careers Page here: https://essentialpharmagroup.com/careers/
51 to 200 staff
Indivior
Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat opioid use disorder (OUD). Our vision is that all patients around the world will have access to evidence-based treatment for OUD and we are dedicated to transforming OUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Headquartered in the United States in Richmond, VA, Indivior employs more than individuals globally and its portfolio of products is available in over 30 countries worldwide. Our guiding principles foster a corporate culture of trust, innovation, and a pioneering spirit: • Focus on patient needs to drive decisions • Seek the wisdom of the team • Believe that people’s actions are well intended • Care enough to coach • See it, own it, make it happen • Demonstrate honesty and integrity at all times Community guidelines: https://bit.ly/43QuKrw
1001 to 5000 staff
Ora
Ora is the world's leading full-service ophthalmic drug and device development firm with offices in the United States, United Kingdom, Australia, and Asia. For over 45 years, we have proudly helped our clients earn more than 85 product approvals. We support a wide array of organizations, from start-ups to global pharmaceutical and device companies, to efficiently bring their new products from concept to market. Ora's pre-clinical and clinical models, unique methodologies, integrated clinical data solutions, and global regulatory strategies have been refined and proven across thousands of global projects. We bring together the world's most extensive and experienced team of ophthalmic experts, R&D professionals, and management executives to maximize the value of new product initiatives.
201 to 500 staff
Animalcare Uk Ltd
Since 1988, Animalcare has offered a wide range of animal health products, from identichip microchips and pharmaceuticals to pet welfare products and practice equipment. We have built an enviable reputation providing innovative, high quality and excellent value products into the veterinary market. We pride ourselves on listening to our customers, sourcing and adapting our products to fulfil their requirements. We strive to achieve the best levels of customer service through our highly trained customer service team and veterinary representatives, creating a high level of customer satisfaction. Our aim is to renew and strengthen our product range throughout the UK and through distribution partners into other key European territories, without compromising any of our core values.
51 to 200 staff
Aurora Cannabis Inc
Aurora Cannabis Inc. is a world-renowned integrated cannabis company with an industry-leading reputation for continuously elevating and setting the global cannabis industry standard. Through our wholly owned subsidiaries, strategic investments, and global partnerships, Aurora provides a wide range of premium quality cannabis and hemp products and services, develops innovative technologies, promotes cannabis consumer health and wellness, and delivers an exceptional customer experience across all its brands. Aurora’s operations span multiple continents and focuses on both the medical and recreational cannabis production and sales, patient education and clinic counselling services, home hydroponic cultivation, extraction technologies and delivery systems, and hemp-based food health products. We operate around the globe pursuing new and emerging cannabis markets where possible through our owned network of import, export and wholesale distributors, and our e-commerce and mobile applications.
1001 to 5000 staff
